Wei-Lien Wang

Sep 16, 2024 | digitalcommons.library.tmc.edu | Prapassorn Thirasastr |Heather Lin |Behrang Amini |Wei-Lien Wang

OBJECTIVE: Well-differentiated (WDLPS) and dedifferentiated liposarcoma (DDLPS) account for the majority of liposarcomas. Although gemcitabine-docetaxel is used as second-line treatment in soft tissue sarcomas, its efficacy in WDLPS/DDLPS is not established. This study retrospectively analyzed the efficacy of gemcitabine regimens in WDLPS/DDLPS.